Noyes, K.
Myneni, A. A.
Schwaitzberg, S. D.
Hoffman, A. B.
Funding for this research was provided by:
Surgical Outcomes and Research (UB SOAR) program at the Department of Surgery, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York
Article History
Received: 10 April 2019
Accepted: 31 May 2019
First Online: 12 June 2019
Compliance with ethical standards
:
: The earlier version of the study was presented at the 2019 SAGES Annual Meeting. Dr. Hoffman is a paid consultant for Ethicon US, LLC (not related to the study). Dr. Steven Schwaitzberg is a paid consultant for Nu View Surgical, Acuity Bio, Activ Surgical, Human Extensions, Levitra Magnetics and Arch Therapeutics (not related to the study). K. Noyes and A. A. Myneni declare that they have no conflict of interest or financial ties to disclose. The American College of Surgeons Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program and the centers participating in the ACS MBSAQIP are the source of the data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors.